                                  DC REGULATIONS

ADMINISTRATION OF DIAGNOSTIC PHARMACEUTICAL AGENTS (ยง 17-6412)

6412.1. For purposes of this section, &#8220;diagnostic pharmaceutical
   agent&#8221; means any pharmaceutical agent used in the diagnosis of ocular
   disease and conditions of the visual system.

   6412.2. Only an optometrist certified in accordance with this section or a
   physician may administer a diagnostic pharmaceutical agent.

   6412.3. An applicant for certification to administer diagnostic pharmaceutical
   agents shall do the following:
   
   
   
   (a)	Submit a completed, notarized application; and
   
   
   
   (b)	Demonstrate to the satisfaction of the Board that he or she:
   
   
   
   (1)	Has either applied for licensure under this chapter as an optometrist, or
   has been issued a license under this chapter as an optometrist;
   
   
   
   (2)	Has completed a course approved by the Board in general and ocular
   pharmacology that meets the requirements of ยง 207 of the Act, D.C. Code ยง
   2-3302.7, and has arranged for the institution to submit a transcript directly
   to the Board; and
   
   
   
   (3)	Has passed the treatment and management of ocular disease (TMOD) section
   of the examination administered by the National Board of Examiners in
   Optometry, or any other examination approved by the National Board of
   Examiners in Optometry or the Board, and has arranged for the test results to
   be submitted directly to the Board.

   6412.4. A course approved by the Board shall be any course in the treatment
   and management of ocular disease offered or approved by an institution with an
   accredited program.

   6412.5. An optometrist authorized under this section to administer a
   diagnostic pharmaceutical agent shall not do the following:
   
   
   
   (a)	Administer a diagnostic pharmaceutical agent by any means other than
   topical application to the eye;
   
   
   
   (b)	Administer a diagnostic pharmaceutical agent when the medical condition of
   the patient contraindicates such use; or
   
   
   
   (c)	Administer any pharmaceutical agent for therapeutic purposes unless
   authorized in accordance with the provisions of section 6413 of this chapter.
   
   
   
   	SOURCE: Final Rulemaking published at 35 DCR 4494, 4502 (June 17, 1988); as
   amended by Final Rulemaking published at 46 DCR 4197 (May 7, 1999).
